Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry
Serna-Higuita, Lina María, Amaral, Teresa, Forschner, Andrea, Leiter, Ulrike, Flatz, Lukas, Seeber, Olivia, Thomas, Ioannis, Garbe, Claus, Eigentler, Thomas Kurt, Martus, Peter
Published in Cancers (06.12.2021)
Published in Cancers (06.12.2021)
Get full text
Journal Article
Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma
Amaral, Teresa, Seeber, Olivia, Mersi, Edgar, Sanchez, Stephanie, Thomas, Ioannis, Meiwes, Andreas, Forschner, Andrea, Leiter, Ulrike, Eigentler, Thomas, Keim, Ulrike, Garbe, Claus
Published in Cancers (22.04.2020)
Published in Cancers (22.04.2020)
Get full text
Journal Article
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy
Chatziioannou, Eftychia, Leiter, Ulrike, Thomas, Ioannis, Keim, Ulrike, Seeber, Olivia, Meiwes, Andreas, Boessenecker, Isabell, Gonzalez, Stephanie Sanchez, Torres, Francisco Merraz, Niessner, Heike, Sinnberg, Tobias, Forschner, Andrea, Flatz, Lukas, Amaral, Teresa
Published in American journal of clinical dermatology (01.05.2023)
Published in American journal of clinical dermatology (01.05.2023)
Get full text
Journal Article